NCT05024422View on ClinicalTrials.gov

Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

November 7, 2022

Conditions
Lactation Suppressed
Interventions
DRUG

Cabergoline

Administration of Cabergoline (one dose of 1mg, up to 24 hours postpartum, or 0.25 mg twice a day for two days)

DRUG

Pyridoxine

Administration of Pyridoxine (200 mg X 3 per day for a week)

Trial Locations (1)

Unknown

HaEmek Medical Center, Afula

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT05024422 - Lactation Inhibition, the Efficiency of Vitamin B6 Versus Cabergoline | Biotech Hunter | Biotech Hunter